• SENSEX 81,463.09
    -721.08 (--0.88%)
  • BANKNIFTY 56,528.90
    -537.15 (--0.94%)
  • Authum Invest
    2,250.00 985.45(%)
  • Indian Energy Ex
    149.45 244.35(%)
  • Vimta Labs
    598.90 598.90(%)
  • Bharti Airtel
    1,952.40 2,045.50(%)
  • Force Motors
    16,488.00 6,128.55(%)
  • Bajaj Finance
    897.65 642.61(%)
  • Anant Raj
    606.00 947.25(%)
  • Jayaswal Neco
    40.05 26.06(%)
  • Sharda Cropchem
    1,090.25 1,090.25(%)
  • Infosys
    1,511.35 1,307.10(%)
  • Olectra Greentec
    1,460.00 973.65(%)
  • Tata Motors
    685.00 542.55(%)
  • Eternal Ltd
    306.25 189.60(%)
  • Trent
    5,033.80 4,491.75(%)
  • Reliance Industr
    1,384.50 1,115.55(%)
  • Waaree Energies
    3,171.00 1,808.65(%)
  • Phoenix Mills
    1,545.00 1,965.00(%)
  • Kajaria Ceramics
    1,151.00 745.00(%)
  • Adani Green
    972.75 758.00(%)
  • Cipla
    1,553.00 1,702.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Sanjivani Paranteral Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 6710.0
  • ISIN : INE860D01013
229.05 -4 (-1.78%)
  • As on 26 Jul 2025 (EOD)

  • Today’s Low

    227.50

  • Today’s High

    236.00

  • Open

    233.20

  • Perv Close

    233.20

  • 52W Low

    199.00

  • 52W High

    396.95

Key Indicators

  • P/E(TTM)

    34.14

  • Mar.Cap (₹Cr.)

    276.67

  • Div & Yield %

    0.21

  • Book Value(₹)

    33.67

  • Debt-Equity Ratio

    -1.78

  • AGM Date

    25-Jul-2025

  • EPS

    6.71

  • P/E Ratio

    34.14

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    276.67

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    12.08

  • BV (₹)

    33.70

  • Sales( ₹ in Cr.)

    70.10

  • NP (in Cr.)

    8.10

  • NP Var(%)

    31.0

  • Div%

    5.0

  • CPS (₹)

    7.20

  • EPS (₹)

    6.70

  • Traded Value (₹ in Lakhs)

    276.67

  • 52 Week High

    396.95

  • 52 Week Low

    199.00

  • Price BSE

    229.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    276.67

  • P/C Ratio

    31.70

  • P/E Ratio

    34.10

  • Price Vs.BV

    6.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 58.95 41.47 30.61 25.10 16.36 25.09
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 58.95 41.47 30.61 25.10 16.36 25.09
Other Income 0.52 0.55 0.24 0.26 0.25 0.96
Stock Adjustments 5.89 1.28 0.35 -0.67 0.86 -0.47
Total Income 65.36 43.30 31.20 24.69 17.47 25.58
EXPENDITURE :            
Raw Materials 34.37 19.84 12.66 14.14 9.93 14.60
Power and Fuel Cost 1.14 1.10 0.98 0.78 0.58 0.73
Employee Cost 3.74 2.91 2.73 2.13 2.25 2.37
Other Manufacturing Expenses 3.24 2.19 1.98 1.08 0.70 0.72
Selling and Administration Expenses 9.45 5.32 7.22 2.91 2.60 2.76
Miscellaneous Expenses 0.12 -0.23 -0.33 1.25 1.48 5.20
Employee Benefit Expenses 3.74 2.91 2.73 2.13 2.25 2.37
Less: Preoperative Expenditure -4.54 -5.98 0.00 0.00 0.00 0.00
Total Expenses 56.60 37.11 25.24 22.30 17.55 26.38
Operating Profit 8.75 6.19 5.97 2.40 -0.08 -0.80
Interest 0.25 0.36 0.21 0.13 0.66 0.33
Gross Profit 8.50 5.83 5.76 2.27 -0.74 -1.13
Depreciation 0.93 0.89 0.88 0.86 1.07 1.17
Profit Before Tax 7.57 4.94 4.88 1.41 -1.81 -2.30
Current Tax 1.36 1.04 0.00 0.00 -0.10 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.05 -0.61 0.03 -0.01 0.00 -0.23
Reported Net Profit 6.17 4.51 4.85 1.42 -1.71 -2.07
Extraordinary Items 0.00 -0.01 0.00 0.00 0.00 0.00
Adjusted Net Profit 6.17 4.52 4.85 1.42 -1.71 -2.07
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward -57.05 -61.56 -66.41 -67.83 -66.12 -64.05
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -50.89 -57.05 -61.56 -66.41 -67.83 -66.12
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 5.28 4.51 4.85 1.67 -2.90 0.00
Earnings Per Share(Adj)-Unit Curr 5.28 4.51 4.85 1.67 -2.90 0.00
Book Value 22.14 -3.07 -7.58 -52.83 -82.93 -80.03
Book Value(Adj)-Unit Curr 22.14 -3.07 -7.58 -52.83 -82.93 -80.03

Shareholding Pattern

  • Promoter Group

    28.87%

  • Public Share Holding

    71.13%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,430,455 28.87 3,430,455 2
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,430,455 28.87 3,430,455 2
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 600,000 5.05 600,000 1
Trusts 0 0.00 0 0
Venture Capital Funds 130,802 1.10 130,802 1
Sub total 730,802 6.15 730,802 2
2] Non Institution
Bodies Corporate 936,281 7.88 936,281 51
Clearing Members 165 0.00 165 3
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 71,662 0.60 71,162 93
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 317,761 2.67 317,761 149
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,417,273 28.76 3,417,273 34
Individuals holding nominal share capital up to Rs. 1 lakh 2,832,089 23.84 2,773,799 6,086
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 604 0.01 604 2
Others 0 0.00 0 0
Sub Total 7,720,437 64.98 7,661,647 6,425
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 11,881,694 100.00 11,822,904 6,429

Company Background

Sanjivani Paranteral LtdPharmaceuticals - Indian - Formulations

  • Sanjivani Paranteral Ltd
  • BSE Code : 6710.0
  • ISIN : INE860D01013

  • Incorporation Year

    1994

  • Registered Office

    205 P N Khotari Indl Estate
    LBS Marg Bhandup (West), Mumbai,
    Maharashtra-400078

  • Telephone

    91-22-67290900

  • FAX

    91-22-67290930

  • Chairman

    Ashwin Khemka

  • Managing Director

    Ashwin Khemka

  • Company Secretary

  • Auditor

    R B Gohil & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Sanjivani Paranteral Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Sanjiv.Parant. 229.05 54.93 54.41 34.14 11.43
Abbott India 33,771.20 6,684.73 6,409.15 50.74 44.95
Astrazeneca Phar 8,832.65 1,756.92 1,716.29 190.77 32.94
P & G Health Ltd 5,831.90 1,166.89 1,151.26 38.54 39.76
Glaxosmi. Pharma 3,154.75 3,866.05 3,723.49 58.15 58.72
Cipla 1,531.10 20,029.57 19,044.85 23.98 21.40
Amrutanjan Healt 679.00 437.58 421.23 38.62 20.84
Fermenta Biotec. 375.35 442.21 430.53 16.34 17.61
Guj. Themis Bio. 363.35 174.19 169.82 81.10 44.82
Bliss GVS Pharma 153.45 703.42 667.20 23.46 9.16
Ambalal Sarabhai 32.88 19.33 4.04 30.44 2.10